During the BIO International Convention 2026 (June 22–25) in San Diego, BioSpectrum Asia spoke with Lan Nguyen, Ch...
While most cardiovascular research has traditionally focused on the heart and large blood vessels, a growing body of evi...
As the pharmaceutical industry advances towards increasingly complex, poorly soluble drug candidates, formulation has ...
NVIDIA announced NVIDIA BioNeMo Agent Toolkit, which provides domain-specific tools and skills for the agentic life scie...
Haisco Pharmaceutical Group has entered into an exclusive licensing agreement with U.S.-based biotechnology company Nuve...
China-based Abbisko Therapeutics has entered into a strategic research collaboration and licence agreement with US-based...
Lys Therapeutics has raised more than €25 million since its founding in 2021 to advance LYS241, its lead neurovascu...
SystImmune and parent company Sichuan Biokin Pharmaceutical have received regulatory approval in China for iza-bren, als...
AnHorn Medicines has received U.S. FDA Investigational New Drug clearance and Taiwan Center for Drug Evaluation Index Ca...
Insilico Medicine, a Hong Kong-based clinical-stage generative artificial intelligence (AI)-driven drug discovery compan...
Japan-based startup Axcelead Drug Discovery Partners (DDP), Inc. has entered a collaboration with Lilly TuneLab, a colla...
Insilico Medicine has completed first-in-human dosing in the Phase I clinical study of ISM8969, an AI-driven small-molec...
South Korea-based LG AI Research has signed a master agreement with D&D Pharmatech for a joint next-generation oral ...
MindWalk Holdings Corp. is positioning biological data infrastructure as a key bottleneck in AI-enabled drug discovery, ...
Hillhurst Bio has dosed the first subject in its Phase 2a clinical trial evaluating HBI-002 for the treatment of Parkins...
Genentech has received U.S. FDA acceptance and Priority Review for its New Drug Application for giredestrant as an adjuv...
Nuvalent has received U.S. FDA acceptance and Priority Review for its New Drug Application for neladalkib in tyrosine ki...
Pfizer has received US FDA approval for an expanded indication of Hympavzi for hemophilia A or B, broadening its use to ...
Shionogi has received US FDA approval for XOCOVA, or ensitrelvir, as an oral post-exposure prophylaxis option for COVID-...
Argo Biopharma will present updated Phase II results for BW-20805, its investigational siRNA therapy for hereditary angi...
VERTANICAL has received marketing authorisation in Germany for Exilby, or VER-01, for the treatment of chronic low back ...
Genentech has received US FDA approval for Tecentriq and Tecentriq Hybreza as adjuvant treatment for adults with muscle-...
The European Medicines Agency has accepted Teva’s Marketing Authorisation Application for olanzapine long-acting i...
Amgen has received European Commission marketing authorisation for IMDYLLTRA, or tarlatamab, as monotherapy for adults w...
AbbVie has received European Commission approval for AQUIPTA, or atogepant, as an acute treatment for migraine in adults...